Lupin, MonoSol Rx ink licensing deal for pediatric products

Lupin Pharmaceutical (NSE:LUPIN) said last week that it inked a licensing agreement with MonoSol Rx to develop pediatric products using MonoSol’s drug delivery technology.

Warren, N.J.-based MonoSol touts its dissolvable film, PharmaFilm, as a quick-dissolving system that’s easy to administer and masked by a taste. The minimally invasive film is designed to support pediatric populations that often have trouble swallowing pills or tolerating more invasive delivery forms.

Get the full story at our sister site, Drug Delivery Business News.

The post Lupin, MonoSol Rx ink licensing deal for pediatric products appeared first on MassDevice.

from MassDevice http://ift.tt/2d4QvPD